Cathie Wood Teva Pharmaceutical Industries LTD Transaction History

Ark Investment Management LLC

$9.28 Billion
Q1 2025

A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Ark Investment Management LLC holds 90,253 shares of TEVA stock, worth $1.51 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

90,253

Previous 100,443 10.15%

Holding current value

$1.51 Million

Previous $2.21 Million 37.32%

% of portfolio

0.01%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 07, 2025	SELL	$14.67 - $22.01 $149,487 - $224,281	-10,190 Reduced 10.15%	90,253 $1.39 Million
Q4 2024 Feb 04, 2025	SELL	$16.43 - $22.77 $384,823 - $533,318	-23,422 Reduced 18.91%	100,443 $2.21 Million
Q3 2024 Oct 31, 2024	SELL	$15.81 - $18.96 $720,224 - $863,722	-45,555 Reduced 26.89%	123,865 $2.23 Million
Q2 2024 Jul 26, 2024	SELL	$12.78 - $17.4 $290,310 - $395,258	-22,716 Reduced 11.82%	169,420 $2.75 Million
Q1 2024 Apr 18, 2024	SELL	$10.67 - $14.43 $327,248 - $442,568	-30,670 Reduced 13.77%	192,136 $2.71 Million
Q4 2023 Jan 17, 2024	SELL	$8.12 - $10.63 $259,872 - $340,202	-32,004 Reduced 12.56%	222,806 $2.33 Million
Q3 2023 Oct 18, 2023	BUY	$7.48 - $10.7 $126,314 - $180,690	16,887 Added 7.1%	254,810 $2.6 Million
Q2 2023 Jul 10, 2023	BUY	$7.2 - $9.47 $188,244 - $247,593	26,145 Added 12.35%	237,923 $1.79 Million
Q1 2023 Apr 17, 2023	SELL	$8.36 - $11.37 $396,138 - $538,767	-47,385 Reduced 18.28%	211,778 $1.87 Million
Q4 2022 Jan 24, 2023	SELL	$7.95 - $9.48 $606,624 - $723,371	-76,305 Reduced 22.75%	259,163 $0
Q3 2022 Oct 17, 2022	BUY	$6.86 - $11.95 $706,237 - $1.23 Million	102,950 Added 44.28%	335,468 $2.71 Million
Q2 2022 Jul 11, 2022	SELL	$7.38 - $10.4 $498,105 - $701,937	-67,494 Reduced 22.5%	232,518 $2.12 Million
Q1 2022 Apr 19, 2022	SELL	$7.33 - $9.39 $35,037 - $44,884	-4,780 Reduced 1.57%	300,012 $2.82 Million
Q4 2021 Jan 28, 2022	SELL	$7.9 - $10.19 $783,711 - $1.01 Million	-99,204 Reduced 24.56%	304,792 $2.44 Million
Q3 2021 Nov 12, 2021	SELL	$8.38 - $10.18 $908,777 - $1.1 Million	-108,446 Reduced 21.16%	403,996 $3.94 Million
Q2 2021 Aug 05, 2021	BUY	$9.9 - $11.56 $124,720 - $145,632	12,598 Added 2.52%	512,442 $5.07 Million
Q1 2021 May 13, 2021	BUY	$10.34 - $12.81 $3.31 Million - $4.1 Million	320,042 Added 178.0%	499,844 $5.77 Million
Q4 2020 Feb 12, 2021	BUY	$8.61 - $11.04 $901,596 - $1.16 Million	104,715 Added 139.46%	179,802 $1.74 Million
Q3 2020 Oct 30, 2020	SELL	$8.57 - $12.69 $213,435 - $316,044	-24,905 Reduced 24.91%	75,087 $677,000
Q2 2020 Aug 11, 2020	BUY	$8.12 - $13.12 $356,216 - $575,561	43,869 Added 78.17%	99,992 $1.23 Million
Q1 2020 May 14, 2020	BUY	$6.69 - $13.45 $66,859 - $134,419	9,994 Added 21.67%	56,123 $504,000
Q4 2019 Jan 31, 2020	SELL	$6.53 - $10.72 $69,015 - $113,299	-10,569 Reduced 18.64%	46,129 $452,000
Q3 2019 Nov 12, 2019	BUY	$6.16 - $9.6 $137,312 - $213,993	22,291 Added 64.79%	56,698 $390,000
Q2 2019 Jul 30, 2019	BUY	$8.12 - $15.72 $80,753 - $156,335	9,945 Added 40.65%	34,407 $318,000
Q1 2019 May 13, 2019	BUY	$15.58 - $20.01 $13,336 - $17,128	856 Added 3.63%	24,462 $384,000
Q4 2018 Feb 01, 2019	BUY	$14.59 - $23.84 $7,922 - $12,945	543 Added 2.35%	23,606 $364,000
Q3 2018 Nov 07, 2018	SELL	$21.06 - $25.65 $156,349 - $190,425	-7,424 Reduced 24.35%	23,063 $497,000
Q2 2018 Aug 07, 2018	BUY	$16.77 - $24.71 $42,947 - $63,282	2,561 Added 9.17%	30,487 $741,000
Q1 2018 May 14, 2018	BUY	$16.68 - $22.07 $179,510 - $237,517	10,762 Added 62.7%	27,926 $477,000
Q4 2017 Feb 12, 2018	BUY	$11.23 - $19.1 $192,751 - $327,832	17,164	17,164 $325,000

Others Institutions Holding TEVA

# of Institutions

660

Shares Held

627M

Call Options Held

27.9M

Put Options Held

21.8M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18.6B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track Cathie Wood's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.

Account